Prognostic value of HALP score in predicting in-hospital mortality in patients with NSTEMI
- PMID: 40008439
- PMCID: PMC11916405
- DOI: 10.1080/17520363.2025.2468144
Prognostic value of HALP score in predicting in-hospital mortality in patients with NSTEMI
Abstract
Aims: We aimed to investigate the association between the HALP score and in-hospital mortality in patients with non-ST segment myocardial infarction (NSTEMI).
Materials and methods: In this retrospective study participants were divided into two groups, based on the median HALP score. Findings were compared between the groups.
Results: A total of 1648 patients included. The median HALP score cutoff value was 3.87. While the low HALP score group (<3.87) included 824 patients, the high HALP score group (>3.87) included 824 patients. Patients with the low HALP score were older and had a higher prevalence of comorbidities. A HALP score ≤ 2.62 predicted in-hospital mortality with sensitivity of 72.5% and a specificity of 77.3% (area under curve 0.809), according to ROC curve analysis. In multivariate analysis, age, diastolic blood pressure, Killip Class > 1 and Syntax Score, creatinine level, LVEF and HALP Score (OR: 0.504, 95% CI: 0.415-0.613; p < 0.001) were independently associated with in-hospital mortality.
Conclusions: According to the current study, the HALP score was independently associated with in-hospital mortality in patients with NSTEMI. Moreover, HALP score might be used as a predictor of in-hospital mortality in this population.
Keywords: HALP score; NSTEMI; Non-ST segment myocardial infarction; mortality; myocardial ischemia.
Conflict of interest statement
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Similar articles
-
The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.Coron Artery Dis. 2023 Nov 1;34(7):483-488. doi: 10.1097/MCA.0000000000001271. Epub 2023 Jul 28. Coron Artery Dis. 2023. PMID: 37799045
-
The Hemoglobin, Albumin, Lymphocyte, and Platelet Score as a Simple Blood-Based Predictor of Residual Coronary Disease Burden in Diabetic Patients with Non-ST-Elevation Myocardial Infarction.Turk Kardiyol Dern Ars. 2025 Aug 7. doi: 10.5543/tkda.2025.71080. Online ahead of print. Turk Kardiyol Dern Ars. 2025. PMID: 40772580 English.
-
A Cross-Sectional Study on the Relationship between the HEART Score and the Severity of CAD using the SYNTAX Score in Patients with NSTEMI Admitted to the Emergency Department: A Study from Turkey.Niger J Clin Pract. 2025 Jun 1;28(6):758-763. doi: 10.4103/njcp.njcp_417_24. Epub 2025 Jun 25. Niger J Clin Pract. 2025. PMID: 40556090
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.Cochrane Database Syst Rev. 2016 May 26;2016(5):CD004815. doi: 10.1002/14651858.CD004815.pub4. Cochrane Database Syst Rev. 2016. PMID: 27226069 Free PMC article.
Cited by
-
Expanding risk stratification in acute coronary syndromes with systemic indices: HALP and CALLY.Biomark Med. 2025 Jun;19(12):451-453. doi: 10.1080/17520363.2025.2517525. Epub 2025 Jun 8. Biomark Med. 2025. PMID: 40485083 No abstract available.
References
-
- ESC Scientific Document Group . 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826. - PubMed
-
•• Cardiovascular disease (CVD) is the most common cause of mortality and morbidity worldwide and the focus of this guideline is on the management of patients with ischaemic heart disease.
-
- Timmis A, Vardas P, Townsend N, et al. European society of cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716–799. - PubMed
-
• This report from the European Society of Cardiology (ESC) Atlas Project highlights cardiovascular disease (CVD) statistics, providing idea about the prevalence of the disease worldwide.
MeSH terms
LinkOut - more resources
Full Text Sources